News

Campbell’s brings soup portfolio to new level

BY Allison Cerra

CAMDEN, N.J. — Campbell’s is bringing modern epicurean offerings to the table.

The company said it is expanding its lineup of soups that are bolder and appeal to diverse palates. The latest innovations include:

  • Six new Campbell’s Go soups, which draw inspiration from global cuisines. The soups, packaged in convenient, microwavable pouches, are available in such varieties as Moroccan-style chicken with chickpeas soup and coconut curry with chicken and shiitake mushrooms soup;

  • Campbell’s Chunky brand is rolling out three new varieties: Jammin’ Jerk chicken with rice and beans, Kickin’ Buffalo-style chicken and chipotle chicken and corn chowder;

  • Four new Campbell’s gourmet bisques, which provide complex layers of on-trend flavor combinations, including sweet potato tomatillo and Thai tomato coconut;

  • Campbell’s Slow Kettle style soups has added two new soup varieties: Kickin’ crab and sweet corn chowder with flame-roasted onions and cayenne pepper and roasted chicken and chardonnay with fire-roasted tomatoes, aged parmesan and pasta; and

  • Campbell’s line of condensed soups now includes sun-ripened yellow tomato soup, which builds on the success of last year’s introduction of harvest orange tomato soup.

"With bolder, more vibrant flavors and contemporary packaging, we’re upping the ante with our new soup offerings," Campbell North America president Mark Alexander said. "Campbell is reframing what soup means, with a variety of new choices that tempt the taste buds and fit the lifestyle of the millennial generation and beyond. This is the new face and flavor of Campbell Soup Co."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Walgreens to shutter certain USA Drug-affiliated stores

BY Allison Cerra

DEERFIELD, Ill. — Walgreens announced plans to close more than half of the stores it is acquiring in its deal with USA Drug.

The company — which said in July it would purchase the mid-South drug store chain for approximately $438 million — confirmed it would close approximately 76 stores across the region. USA Drug operates 144 stores under the USA Drug, Super D Drug, May’s Drug, Med-X and Drug Warehouse banners.

"Although we have not completed the purchase of the USA Drug chain, we are taking steps in anticipation of the completion of the transaction, which is expected to occur in mid-September," Walgreens spokesman Jim Graham told DSN. "After careful planning and market analysis, on Monday we began to notify employees of our intent to close [the stores]. Our decisions about store closures are based on a number of considerations, including size of the market and proximity to other Walgreens and USA Drug stores and affiliates. We expect to close the stores by November."

In its initial acquisition announcement, Walgreens said that the acquired drug stores would continue to operate under their current brand names after the transaction closes, and decisions would be made over time regarding the best, most effective way to harmonize Walgreens and the acquired brands.

"When a store is closed, all its prescription drug customers will be notified of the location of a nearby Walgreens or USA Drug-affiliated store where their prescription information will be transferred," Graham noted. "No other action is needed by pharmacy customers to have their existing prescriptions filled at any Walgreens store."

USA Drug ranked No. 31 on the DSN PoweRx 50, with projected pharmacy sales of approximately $409 million in 2011. For a complete USA Drug profile, see DSN PoweRx Players 2012.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Lilly, BI launch diabetes-education program

BY Alaric DeArment

INDIANAPOLIS — Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

The companies, which have had a deal to develop drugs for diabetes since January 2011 and co-market the drugs Tradjenta (linagliptin) and Jentadueto (linagliptin and metformin), announced Thursday the creation of My Well Planner, a lifestyle-improvement program for adults with the disease.

The program is a free resource for adults with Type 2 diabetes modeled on a behavioral-change approach that offers customized educational content and is designed to help patients and their healthcare providers set small lifestyle goals, featuring topics like general information about the disease, better eating habits, physical activity and others, the companies said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES